Molecular mechanism of vSGLT inhibition by gneyulin reveals antiseptic properties against multidrug-resistant gram-negative bacteria.


Journal

Journal of molecular modeling
ISSN: 0948-5023
Titre abrégé: J Mol Model
Pays: Germany
ID NLM: 9806569

Informations de publication

Date de publication:
11 Jun 2019
Historique:
received: 30 10 2018
accepted: 22 05 2019
entrez: 13 6 2019
pubmed: 13 6 2019
medline: 18 12 2019
Statut: epublish

Résumé

Faced with the worldwide spread of multidrug-resistant (MDR) bacterial strains, together with a lack of any appropriate treatment, urgent steps to combat infectious diseases should be taken. Usually, bacterial components are studied to understand, by analogy, the functioning of human proteins. However, molecular data from bacteria gathered over the past decades provide a sound basis for the search for novel approaches in medical care. With this current work, we want to direct attention to inhibition of the vSGLT glucose transporter from Vibrio parahaemolyticus belonging to the sodium solute symporter (SSS) family, to block sugar transport into the bacterial cell and, as a consequence, to limit its growth. Potential bacteriostatic properties can be drawn from commercially available drugs developed for human diseases. This goal can also be reached with natural components from traditional herbal medicine. The presented data from the numerical analysis of 44 known inhibitors of sodium glucose symporters shed light on potential novel approaches in fighting Gram-negative multidrug-resistant microorganisms. Graphical abstract Molecular view on vSGLT channel inhibition by gneyulin B, the compound of natural origin.

Identifiants

pubmed: 31187300
doi: 10.1007/s00894-019-4073-9
pii: 10.1007/s00894-019-4073-9
doi:

Substances chimiques

Ligands 0
Sodium-Glucose Transport Proteins 0
Stilbenes 0
gneyulin B 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

186

Subventions

Organisme : Narodowe Centrum Nauki
ID : 2015/19/B/NZ7/02380
Organisme : Fundacja na rzecz Nauki Polskiej
ID : HOMING PLUS/2013-8/6
Organisme : Wroclawskie Centrum Sieciowo-Superkomputerowe, Politechnika Wroclawska
ID : 274

Références

J Biol Chem. 2000 Aug 18;275(33):25711-6
pubmed: 10835424
J Biol Chem. 2000 Aug 25;275(34):25959-64
pubmed: 10852908
Physiology (Bethesda). 2004 Dec;19:370-6
pubmed: 15546855
Diabetes Metab Res Rev. 2005 Jan-Feb;21(1):31-8
pubmed: 15624123
J Comput Chem. 2005 Dec;26(16):1781-802
pubmed: 16222654
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Science. 2008 Aug 8;321(5890):810-4
pubmed: 18599740
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
J Comput Chem. 2010 Mar;31(4):671-90
pubmed: 19575467
J Nat Prod. 2010 Apr 23;73(4):763-7
pubmed: 20192242
Nature. 2010 Dec 16;468(7326):988-91
pubmed: 21131949
Cell Biochem Biophys. 2012 Jun;63(2):151-8
pubmed: 22383112
Curr Protoc Bioinformatics. 2014 Sep 08;47:5.6.1-32
pubmed: 25199792
Biochimie. 2015 Aug;115:187-93
pubmed: 26086341
Molecules. 2016 Aug 27;21(9):
pubmed: 27618891
Molecules. 2017 Nov 22;22(11):null
pubmed: 29165360
Biochim Biophys Acta. 1994 Jun 29;1197(2):133-66
pubmed: 8031825

Auteurs

Daniel Wiczew (D)

Faculty of Chemistry, Wroclaw University of Science and Technology, Norwida 4/6, 50-370, Wroclaw, Poland.

Anna Borowska (A)

Faculty of Chemistry, Wroclaw University of Science and Technology, Norwida 4/6, 50-370, Wroclaw, Poland.

Kinga Szkaradek (K)

Faculty of Chemistry, Wroclaw University of Science and Technology, Norwida 4/6, 50-370, Wroclaw, Poland.

Tomasz Biegus (T)

Faculty of Chemistry, Wroclaw University of Science and Technology, Norwida 4/6, 50-370, Wroclaw, Poland.

Kamil Wozniak (K)

Faculty of Chemistry, Wroclaw University of Science and Technology, Norwida 4/6, 50-370, Wroclaw, Poland.

Marcelina Pyclik (M)

Faculty of Chemistry, Wroclaw University of Science and Technology, Norwida 4/6, 50-370, Wroclaw, Poland.

Magdalena Sitarska (M)

Faculty of Chemistry, Wroclaw University of Science and Technology, Norwida 4/6, 50-370, Wroclaw, Poland.

Lukasz Jaszewski (L)

Faculty of Chemistry, Wroclaw University of Science and Technology, Norwida 4/6, 50-370, Wroclaw, Poland.

Lukasz Radosinski (L)

Faculty of Chemistry, Division of Bioprocess and Biomedical Engineering, Wroclaw University of Science and Technology, Norwida 4/6, 50-370, Wroclaw, Poland.

Beata Hanus-Lorenz (B)

Faculty of Fundamental Problems of Technology, Department of Biomedical Engineering, Wroclaw University of Science and Technology, Wybrzeze Wyspianskiego 27, 50-370, Wroclaw, Poland.

Sebastian Kraszewski (S)

Faculty of Fundamental Problems of Technology, Department of Biomedical Engineering, Wroclaw University of Science and Technology, Wybrzeze Wyspianskiego 27, 50-370, Wroclaw, Poland. sebastian.kraszewski@pwr.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH